Intellectual property, technology transfer and manufacture of low-cost HPV vaccines in India

Nature Biotechnology

Volumn 28, Issue 7, 2010, Pages 671-678

  Padmanabhan, Swathi ^a   Amin, Tahir ^b   Sampat, Bhaven ^c   Cook Deegan, Robert ^a   Chandrasekharan, Subhashini ^a  

^a DUKE UNIVERSITY   (United States)

^b Initiative for Medicines Access and Knowledge   (United States)

^c Mailman School of Public Health   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ANTIGEN; WART VIRUS VACCINE; HUMAN PAPILLOMAVIRUS VACCINE L1, TYPE 6,11,16,18;

DRUG COST; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; INDIA; NONHUMAN; PATENT; PRIORITY JOURNAL; REVIEW; TECHNOLOGY; UTERINE CERVIX CANCER; VACCINE PRODUCTION; COST; ECONOMICS; HEALTH CARE DELIVERY; SUPPLY AND DISTRIBUTION; SYNTHESIS;

COSTS AND COST ANALYSIS; HEALTH SERVICES ACCESSIBILITY; INDIA; INTELLECTUAL PROPERTY; PAPILLOMAVIRUS VACCINES; TECHNOLOGY TRANSFER;

EID: 77954492013     PISSN: 10870156     EISSN: 15461696     Source Type: Journal    
DOI: 10.1038/nbt0710-671     Document Type: Review

References (42)

1. Agosti, J.M. et al. N. Engl. J. Med. 356, 1908-1910 (2007).
2. Gakidou, E. et al. PLoS Med. 5, e132 (2008).
3. Lowy, D.R. et al. J. Clin. Invest. 116, 1167-1173 (2006).
4. CDC Vaccine Price List. http://www.cdc.gov/vaccines/programs/vfc/cdc-vac- price-list.htm (accessed 20 January 2010).
5. Anonymous. Making cervical cancer vaccines widely available in developing countries: cost and financing issues. (International aIDs Vaccine Initiative, new York and PatH, seattle, March 2008; accessed 20 January 2010). http://screening.iarc.fr/doc/IaVI-PatH-HPV- financing-brief.pdf.
6. Anonymous. HPV vaccine adoption in developing countries: cost and financing issues. (International aIDs Vaccine Initiative, new York and PatH, seattle, March 2008; accessed 20 January 2010). http://www.rho.org/files/IaVI- PatH-HPV-financing.pdf.
7. Kaiser, J. Science 320, 860 (2009).
8. Anonymous. India's first vaccine for cervical cancer launched. Thaindian News 20 October 2008 http://www.thaindian.com/newsportal/health/indias-first- vac-cine-for-cervical-cancer-launched-100109462.html (accessed 20 January 2010).
9. Goldie, S.J. et al. Reprod. Health Matters 16, 86-96 (2008).
10. Diaz, M. et al. Br. J. Cancer 99, 230-238 (2008).
11. Schiller, J.T. et al. Vaccine 24, 147-153 (2006).
12. Anonymous. Donating more than one million vaccines to help nicaraguan babies. (Merck, Whitehouse station, new Jersey, 2009, 2010; accessed 20 January 2010) http://www.merck.com/responsibil-ity/access/access-feature-nicaraguan. html.
13. Anonymous. GsK Rotavirus vaccine donation to Good shepherd social Welfare services Babies Home (Good shepherd sisters taiwan, 14 December 2006; accessed 20 January 2010) http://www.goodshep-herd.org.tw/eng/index.php?option=com- content&tas k=view&id=64&Itemid=54
14. Harner-Jay, C. et al. J. Pharm. Sci. X, 1-4 (2008).
15. Anonymous. Gardasil access Program. (accessed 20 January 2010). http://gardasil-access-program.org/index.php
16. Batson, A. et al. Vaccine 24, 219-225 (2006).
17. Ghandi, G. Update on GaVI alliance: renewed strategic vision and governance. (UnICeF, Copenhagen, 10-11 December 2008; accessed 20 January 2010) http://www.unicef.org/supply/files/3-GaVI-Vaccine-Pre-tender-Meeting(10Dec08) -GGandhi-v3.pdf.
18. Anonymous. all girls deserve protection from cervical cancer. (GaVI alliance, Geneva, 4 February 2009; accessed 20 January 2010) http://www. gavialliance.org/media-centre/press-releases/HPV- World-Cancer-Day.php.
19. Lydon, P. et al. Vaccine 26, 6706-6716 (2008).
20. Jodar, L. & Clemens, J.D. in The Grand Challenge for the Future Vaccines for Poverty-Related Diseases from Bench to Field (eds. Kaufmann, s.H.e. &Lambert, P.H.) 55-73 (Birkhäuser, Basel, 2005).
21. Anonymous. GaVI alliance Progress Report (GaVI alliance, Geneva 2007; accessed 20 January 2010) http://www.gavialliance.org/resources/2007GaVIreport. pdf
22. Anonymous. Global progress toward universal childhood hepatitis B vaccination. MMWR Weekly, 12 september 2003 http://www.cdc.gov/mmwr/preview/ mmwrhtml/mm5236a5.htm (accessed 20 January 2010).
23. Milstien, J.B. et al. Health Aff. 25, 1061-1069 (2006).
24. Maybarduk, P. & Rimmington, s. Am J. Law Med. 35, 323-350 (2009).
25. Outterson, K. et al. Health Aff. 27, 130-139 (2008).
26. Aankaranarayanan, R. et al. Vaccine 26, M43-M52 (2008).
27. Ferlay, J. et al. GLOBOCAN2002: Cancer incidence, mortality and prevalence worldwide. IaRC Cancer Base no.5 Version 2.0. (IaRC Press, Lyon, France, 2004).
28. Inglis, S. et al. Vaccine 24, 99-105 (2006).
29. Sankaranarayanan, R. et al. Vaccine 26S, M43-M52 (2008).
30. Jagu, S. et al. J. Natl. Cancer Inst. 101, 782-792 (2009).
31. Fraillery, D. et al. Clin. Vaccine Immunol. 14, 1285-1295 (2007).
32. Sinha, G.P. shantha developing $15 cervical cancer vaccine. The Economic Times 16 Oct 2007 http://economictimes.indiatimes.com/news/news-By- Industry/shantha-developing-15-cervical-cancer- vaccine/articleshow/2461640.cms (accessed 20 January 2010).
33. Milstien, J.B. et al. Vaccine 25, 7610-7619 (2007).
34. Chokshi, D.A. et al. J. Am. Med. Assoc. 298, 1934-1936 (2007).
35. Chaifetz, S. et al. Global. Health 3, 1 (2007).
36. Mahoney, R.T. et al. Vaccine 22, 786-792 (2004).
37. Salicrup, L.A. et al. Biotechnol. Adv. 24, 69-79 (2006)
38. Batson, A. Health Aff. 27, 140-142 (2008).
39. MIHR/PIPRa. IP Handbook of Best Practices Rotavirus Vaccine: NIH Office of Technology Transfer case study. http://www.iphandbook.org/handbook/case- studies/cs13/(accessed 20 January 2010).
40. Salicrup, L.A. Nat. Biotechnol. 25, 976-977 (2007).
41. Kane, M.A. et al. Vaccine 24, 132-139 (2006).
42. BigPatents India. http://india.bigpatents.org/(accessed 20 January 2010).